;   Medical Translation Insight: Pharma consolidation slows CRO market - ForeignExchange Translations

Pharma consolidation slows CRO market

Pharma consolidation slows CRO marketCenterWatch reported today that the current wave of pharmaceutical consolidation is leading to increased pressures for drug sponsors to control costs and improve efficiency. This in term is leading to short-term pressures on clinical research organizations (CROs) and other suppliers involved in clinical research - projects are being canceled, delayed, or or re-conceptualized.

We have seen some of that in our business, both in terms of fewer project (due to cancellations and "in-sourcing" of work) and a new hyper-sensitivity to price. In some instances, this is also leading sponsors taking on the management of translations on their research studies, cutting out their CROs.

What about you? Are you seeing fewer clinical research-related translations being done?


Post a Comment


Services | Resources | Company | Contact Us | Blog | Home

(c) Copyright 2010, ForeignExchange Translations, Inc.